- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04800289
Evaluation of Patient Satisfaction and Therapeutic Impact Regarding Joint Consultation Rheumatologist/Dermatologist (RHUMPSO)
March 12, 2021 updated by: Centre Hospitalier le Mans
Current increase in the number of multidisciplinary consultations, but little documentation on their impact on patient management.
More specifically, in the context of psoriatic arthritis, we are seeking to investigate the interest for the patient, through his or her satisfaction and the evolution of the activity of his or her pathology, of a global, joint management in Rheumatology and Dermatology.
Study Overview
Study Type
Observational
Enrollment (Anticipated)
600
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christelle JADEAU
- Phone Number: 02 43 43 43 43
- Email: cjadeau@ch-lemans.fr
Study Contact Backup
- Name: Emmanuelle DERNIS
- Phone Number: 02 43 43 43 43
- Email: edernis@ch-lemans.fr
Study Locations
-
-
-
Le Mans, France, 72000
- Recruiting
- Centre Hospitalier du Mans
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients received in a joint rheumatologist/dermatologist consultation at the Le Mans Hospital
Description
Inclusion Criteria:
- All patients received in a joint rheumatologist/dermatologist consultation at the Le Mans Hospital
Exclusion Criteria:
- Diagnosis of psoriatic arthritis not retained
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
impact on patient satisfaction and the evolution of their pathology of these mixed consultations, Dermatologist and Rheumatologist, in the context of psoriatic arthritis.
Time Frame: 5 years after inclusion
|
evaluate the impact on patient satisfaction and the evolution of their pathology of these mixed consultations, Dermatologist and Rheumatologist, in the context of psoriatic arthritis.
|
5 years after inclusion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 19, 2020
Primary Completion (Anticipated)
July 31, 2030
Study Completion (Anticipated)
July 31, 2030
Study Registration Dates
First Submitted
March 12, 2021
First Submitted That Met QC Criteria
March 12, 2021
First Posted (Actual)
March 16, 2021
Study Record Updates
Last Update Posted (Actual)
March 16, 2021
Last Update Submitted That Met QC Criteria
March 12, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHM-2019/S7/11
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psoriatic Arthritis
-
AmgenRecruitingActive Juvenile Psoriatic ArthritisSpain, France, Greece, Italy, United Kingdom, Austria, Germany, Netherlands, Lithuania, Romania, South Africa, Portugal, Belgium, Turkey (Türkiye), Poland
-
Universitätsklinikum Hamburg-EppendorfBristol-Myers Squibb; Eli Lilly and Company; UCB Pharma; Merck Sharp & Dohme LLC; AbbVi... and other collaboratorsRecruiting
-
Dr. Schär AG / SPAASST Gaetano Pini-CTOCompleted
-
Bristol-Myers SquibbCompletedPsoriatic Arthritis (PsA)Germany
-
Pope Research CorporationAmgenWithdrawn
-
Medical College of WisconsinNot yet recruitingPsoriatic Arthritis (PsA)United States
-
Sun Pharmaceutical Industries LimitedActive, not recruitingActive Psoriatic ArthritisUnited States, Australia, Czechia, Germany, India, Japan, Poland, Spain, South Korea
-
AbbVieActive, not recruitingPsoriatic Arthritis (PsA)United States, Australia, Belgium, Canada, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, New Zealand, Puerto Rico, Singapore, South Africa, Spain, Sweden, United Kingdom, Argentina, Brazil, Denmark, P... and more
-
Chao JiEnrolling by invitationSubclinical Psoriatic ArthritisChina
-
Sun Pharmaceutical Industries LimitedCompleted
Clinical Trials on questionnaires
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Completed
-
University Hospital, ToulouseNot yet recruiting
-
Direction Centrale du Service de Santé des ArméesCompleted
-
Sun Yat-sen UniversityNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingIntensive Care Unit Syndrome | Pediatric Post-intensive Care SyndromeFrance
-
Nova Scotia Health AuthorityNot yet recruitingStroke | Amputation | Spinal Cord Injury | Caregivers | Wheelchair Users | Wheelchair Service ProvidersCanada
-
M.D. Anderson Cancer CenterCompletedAdvanced Cancer | Malignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
The University of Hong KongCompleted
-
Centre Hospitalier Universitaire DijonCompleted
-
UNC Lineberger Comprehensive Cancer CenterCompletedBreast Cancer | MetastasisUnited States